Filing Flows › Trulieve Cannabis (TRLV) › Capital expenditures
Trulieve Cannabis (TRLV) capital expenditures by quarter
Trulieve Cannabis' capital expenditures were $29.0M in Q3 2026 (third quarter 2026), +38% from Q2 2026. Over the last 7 quarters it ranged from $3.4M (Q4 2025) to $29.0M (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $29.0M | +38% | +136% |
| Q2 2026 | $21.0M | +56% | +81% |
| Q1 2026 | $13.5M | +297% | -20% |
| Q4 2025 | $3.4M | -72% | — |
| Q3 2025 | $12.3M | +6% | — |
| Q2 2025 | $11.6M | -31% | — |
| Q1 2025 | $16.9M | — | — |
Q3 2026 at a glance
Trulieve Cannabis, Q3 2026: revenue $230M (-20% year over year), operating margin 18.5%, net earnings $869K, operating cash flow $74.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Trulieve Cannabis' capital expenditures?
Trulieve Cannabis' capital expenditures were $29.0M in Q3 2026 (third quarter 2026), +38% from Q2 2026.
How has Trulieve Cannabis' capital expenditures changed?
Over the last 7 quarters it ranged from $3.4M (Q4 2025) to $29.0M (Q3 2026).